pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,379 catalysts · 5,063 phase readout · 2,308 8k filing · 316 pdufa · 271 earnings · 108 phase 2 completion · 50 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: pdufa×clear all
type
  • phase readout5,063
  • 8k filing2,308
  • pdufa316
  • earnings271
  • phase 2 completion108
  • phase 1 completion50
  • phase 1 2 completion
28
  • phase 1 initiation22
  • phase 0 trial completion21
  • phase 1 2 initiation9
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›RECRUITINGphase readoutNCT07687979: Mobile Application for Gait Training in Parkinson's Disease

    Sponsor: Ege University. Phase: NA. Conditions: PARKINSON DIS

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07128446: COPM-Based Goal Setting Strategies in the PICU

    Sponsor: Samsung Medical Center. Phase: NA. Conditions: Critical Illness, Pediatric Intensive Care Unit

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07709546: Closed Incision NPWT to Prevent Wound Complications Post-ECMO

    Sponsor: St. Antonius Hospital. Phase: NA. Conditions: ExtraCorporeal Membrane Oxygenation (ECMO), Wound Complications, Surgical Site Infection (SSI)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06540079: BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP S

    Sponsor: Biotronik, Inc.. Phase: NA. Conditions: Sinus Node Dysfunction, Bradycardia, Atrioventricular Block

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07395479: A Platform Study of In Vivo CAR-T for Treating Advanced Malignant Tumors Based on Target Screening

    Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Phase: EARLY_PHASE1. Conditions: Advanced Malignant Tumours

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06386796: Renal Resistive Index as a Predictor of Acute Renal Impairment in High-risk Patients

    Sponsor: Aswan University. Phase: . Conditions: Acute Kidney Injury, Critical Illness

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT06702579: Home Monitoring in Hemophilia A

    Sponsor: Radboud University Medical Center. Phase: . Conditions: Hemophilia A, Anticoagulant Therapy, Monitoring, Point of Care Testing, Qualitative Research

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05067179: Analysis of Human ALS Tissues and Registry of ALS Patients

    Sponsor: University of Illinois at Chicago. Phase: . Conditions: Amyotrophic Lateral Sclerosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05318196: Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases

    Sponsor: University Hospital, Toulouse. Phase: . Conditions: Acute Kidney Injury, Chronic Kidney Diseases, Solid-organ Transplantation, Cancer, Metabolic Disease, Immune Diseases

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07274579: An Artificial Intelligence Model for Aiding Claudin18.2 Expression Diagnosis in Gastric Adenocarcinoma

    Sponsor: Nanfang Hospital, Southern Medical University. Phase: . Conditions: Digestive Oncology

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05212428: DNA Sequencing in Clinical Practice, Mayo Clinic Health Tapestry Study

    Sponsor: Mayo Clinic. Phase: NA. Conditions: Genetic Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07310628: Comparison of Analgesic Efficacy of Intrathecal Levobupivacaine With and Without Oral Tizanidine in Lower Limb Surgeries: A Prospective Randomized Study

    Sponsor: All India Institute of Medical Sciences. Phase: PHASE4. Conditions: Tizanididne, Levobupicaine, Lower Limb Surgery, Pain, Chronic

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04052828: Fetal Endoscopic Tracheal Occlusion (FETO) Trial for Congenital Diaphragmatic Hernia (CDH)

    Sponsor: Dr Erin Perrone. Phase: NA. Conditions: Congenital Diaphragmatic Hernia

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07250828: Efficacy and Feasibility of BurstDR SCS in Painful Diabetic Neuropathy

    Sponsor: TriCity Research Center. Phase: NA. Conditions: Painful Diabetic Neuropathy (PDN), Diabetic Neuropathy, Neuropathic Pain, Chronic Pain

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05094128: A Study to Assess Disease Activity in Adult Participants With Axial Spondyloarthritis Who Receive Upadacitinib in a Real-world Setting

    Sponsor: AbbVie. Phase: . Conditions: Axial Spondylarthritis (r-axSpA)

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT05118867: Improve the Patients' Recovery With Family- Caregivers to End Delirium

    Sponsor: Mayo Clinic. Phase: NA. Conditions: Delirium

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07490600: Contingency Management Plus Deep Transcranial Magnetic Stimulation for the Treatment of Cocaine Use Disorder

    Sponsor: The University of Texas Health Science Center, Houston. Phase: NA. Conditions: Cocaine Use Disorder (CUD)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05140200: Study of GSK3511294 in Healthy Chinese Participants

    Sponsor: GlaxoSmithKline. Phase: PHASE1. Conditions: Asthma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07088107: A Neurofeedback Interface in Poststroke Neuromodulation Using TMS-fNIRS

    Sponsor: The Hong Kong Polytechnic University. Phase: NA. Conditions: Stroke

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07105800: Dance Intervention to Improve Executive Function and Physical Performance in Older Adults With Cognitive Impairment

    Sponsor: Taipei Medical University Shuang Ho Hospital. Phase: NA. Conditions: Older Adults, Cognitive Impairment, Mild

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06547736: Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer

    Sponsor: Fudan University. Phase: PHASE2. Conditions: Pancreatic Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02812134: Impact of Oral Phosphorus Supplements on the 6-month Change in FGF23 Levels in Anorexic Adolescents Suffering From Undernutrition.

    Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: . Conditions: Malnutrition

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02692664: Prospective Multicenter Study for the Endovascular Treatment of Iliac Aneurysm With the Branched E-liac Stent Graft

    Sponsor: JOTEC GmbH. Phase: . Conditions: Iliac Aneurysm, AAA

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07578909: Retro Walking With and Without Bosu Ball for Balance and Mobility in Hearing Impaired Children

    Sponsor: Riphah International University. Phase: NA. Conditions: Hearing Impaired Children

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06155409: Safety and Performance of the SPINEVISION Hexanium ACIF in the Treatment of Cervical Spine Degenerative Disc Disease

    Sponsor: SPINEVISION SAS. Phase: . Conditions: Intervertebral Disc Degeneration

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06203899: Depression and Suicide Prevention in Adolescents Attending Special Schools

    Sponsor: Ggz Oost Brabant. Phase: NA. Conditions: Depressive Symptoms

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05160532: Intraarticular Dextrose Prolotherapy for Symptomatic Knee Osteoarthritis

    Sponsor: Mayo Clinic. Phase: PHASE2. Conditions: Knee Osteoarthritis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04673032: Radiofrequency (RF) Ablation Prospective Outcomes Study

    Sponsor: Boston Scientific Corporation. Phase: . Conditions: Pain, Chronic

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05717998: Imaging and Blood-Based Biomarkers for the Evaluation of Early Signs of Myocardial Injury After Thoracic Radiation Therapy

    Sponsor: Ohio State University Comprehensive Cancer Center. Phase: . Conditions: Lung Non-Small Cell Carcinoma, GastroEsophageal Cancer, Esophagus Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05714163: Effects of Ai Chi on Scapular Muscle Activation in Overhead Athletes With Scapular Dyskinesis

    Sponsor: National Taiwan University Hospital. Phase: . Conditions: Scapular Dyskinesis, Athletic Injuries, Muscle Weakness, Overuse Injury

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03420963: Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Recurrent Cutaneous Melanoma, Recurrent Lip and Oral Cavity Carcinoma, Recurrent Malignant Endocrine Neoplasm, Recurrent Malignant Female Reproductive System Neoplasm, Recurrent Malignant Male Reproductive System Neoplasm, Recurrent Malignant Mesothelioma, Recurrent Malignant Neoplasm of Multiple Primary Sites, Recurrent Malignant Oral Neoplasm, Recurrent Malignant Pharyngeal Neoplasm, Recurrent Malignant Skin Neoplasm, Recurrent Malignant Soft Tissue Neoplasm, Recurrent Malignant Solid Neoplasm, Recurrent Malignant Thyroid Gland Neoplasm, Recurrent Malignant Urinary System Neoplasm, Refractory Cutaneous Melanoma, Refractory Malignant Bone Neoplasm, Refractory Malignant Endocrine Neoplasm, Refractory Malignant Female Reproductive System Neoplasm, Refractory Malignant Male Reproductive System Neoplasm, Refractory Malignant Mesothelioma, Refractory Malignant Neoplasm of Multiple Primary Sites, Refractory Malignant Oral Neoplasm, Refractory Malignant Pharyngeal Neoplasm, Refractory Malignant Skin Neoplasm, Refractory Malignant Soft Tissue Neoplasm, Refractory Malignant Solid Neoplasm, Refractory Malignant Thyroid Gland Neoplasm, Refractory Malignant Urinary System Neoplasm

    full page →ctgov ↗
    ›WITHHELDphase readoutNCT06853093: [Trial of device that is not approved or cleared by the U.S. FDA]

    Sponsor: [Redacted]. Phase: . Conditions:

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06638463: My Health Coach App RCT

    Sponsor: University of Rochester. Phase: NA. Conditions: Fetal Alcohol Spectrum Disorders

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05220163: Evaluating the Impact of Computer-assisted X-ray Diagnosis and Other Triage Tools to Optimise Xpert Orientated Community-based Active Case Finding for TB and COVID-19

    Sponsor: University of Cape Town. Phase: NA. Conditions: Tuberculosis, COVID-19, HIV Infections

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06712563: Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting

    Sponsor: AstraZeneca. Phase: . Conditions: Pulmonary Disease, Chronic Obstructive

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT05852587: Xylitol Use for Decolonization of C. Difficile in Patients With IBD

    Sponsor: Brigham and Women's Hospital. Phase: PHASE1. Conditions: Inflammatory Bowel Diseases, Clostridioides Difficile Infection

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05534321: Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease

    Sponsor: Baptist Health South Florida. Phase: PHASE1. Conditions: Spine Metastases

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05902221: Impact of Rifampicin in Treatment Outcome of Cutibacterium Acnes Prosthetic Joint Infections

    Sponsor: Centre Hospitalier Universitaire de Nice. Phase: PHASE3. Conditions: Infections Joint Prosthetic

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06335121: Implementation of PrEP Care Among Women in Family Planning Clinics

    Sponsor: Rush University Medical Center. Phase: NA. Conditions: PrEP Uptake, HIV, Prevention

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT02354014: Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TB

    Sponsor: Janssen Research & Development, LLC. Phase: PHASE2. Conditions: Tuberculosis, Multidrug-Resistant

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07377006: Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer

    Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Prostate Carcinoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03705806: Palliative Thoracic ImmunoRT

    Sponsor: University Health Network, Toronto. Phase: . Conditions: Lung Cancer, Nonsmall Cell, Lung Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05862584: Impact of Air Pollution on the Course of Inflammatory Rheumatism

    Sponsor: Centre Hospitalier Universitaire de Nice. Phase: NA. Conditions: Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06613984: Korean Post Marketing Surveillance for Comirnaty Injection (Bretovameran)

    Sponsor: Pfizer. Phase: . Conditions: COVID-19 Vaccination

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07167784: Ecological Momentary Assessment and Physical Activity in Patients With Inflammatory Rheumatic Diseases

    Sponsor: University Hospital, Grenoble. Phase: . Conditions: Spondyloarthritis (SpA), Rheumatoid Arthritis & Other Inflammatory Polyarthropathies

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT05600933: Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment

    Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Solid Tumors, Hematologic Malignancy, Gastrointestinal Cancer, Liver Cancer, Pancreatic Cancer, Melanoma, Pre-Malignancy, Lung Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01413152: Residual Risk Assessment Of HIV Transmission

    Sponsor: French National Agency for Research on AIDS and Viral Hepatitis. Phase: NA. Conditions: HIV Infection

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06401733: Intensive Aerobic and Resistance Exercise Program (IAREP)

    Sponsor: National University of Singapore. Phase: NA. Conditions: Type 2 Diabetes Mellitus, Cognitive Impairment, Non-insulin-dependent Diabetes Mellitus, Cognitive Dysfunction

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06959433: Lu-177 PSMA Treatment in Cell Renal Carcinoma

    Sponsor: Ankara University. Phase: PHASE3. Conditions: Metastatic Renal Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06944652: Stretching to Improve Jumping Performance

    Sponsor: University of Saskatchewan. Phase: NA. Conditions: Vertical Jump Performance

    full page →ctgov ↗
    ← prev
    page 97 of 108
    next →